These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 32512236)

  • 1. Circumventing colistin resistance by combining colistin and antimicrobial peptides to kill colistin-resistant and multidrug-resistant Gram-negative bacteria.
    Witherell KS; Price J; Bandaranayake AD; Olson J; Call DR
    J Glob Antimicrob Resist; 2020 Sep; 22():706-712. PubMed ID: 32512236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of antimicrobial peptide CDP-B11 alone and in combination with colistin against colistin-resistant and multidrug-resistant Escherichia coli.
    Witherell KS; Price J; Bandaranayake AD; Olson J; Call DR
    Sci Rep; 2021 Jan; 11(1):2151. PubMed ID: 33495505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-sensitization of Multidrug-Resistant and Colistin-Resistant Gram-Negative Bacteria to Colistin by Povarov/Doebner-Derived Compounds.
    Onyedibe KI; Nemeth AM; Dayal N; Smith RD; Lamptey J; Ernst RK; Melander RJ; Melander C; Sintim HO
    ACS Infect Dis; 2023 Feb; 9(2):283-295. PubMed ID: 36651182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial effect of rose bengal against colistin-resistant gram-negative bacteria.
    Kurosu M; Mitachi K; Pershing EV; Horowitz BD; Wachter EA; Lacey JW; Ji Y; Rodrigues DJ
    J Antibiot (Tokyo); 2023 Jul; 76(7):416-424. PubMed ID: 37076631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Anthelmintic Drug Niclosamide Synergizes with Colistin and Reverses Colistin Resistance in Gram-Negative Bacilli.
    Domalaon R; De Silva PM; Kumar A; Zhanel GG; Schweizer F
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic combinations of anthelmintic salicylanilides oxyclozanide, rafoxanide, and closantel with colistin eradicates multidrug-resistant colistin-resistant Gram-negative bacilli.
    Domalaon R; Okunnu O; Zhanel GG; Schweizer F
    J Antibiot (Tokyo); 2019 Aug; 72(8):605-616. PubMed ID: 31028351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018.
    Lee YL; Lu MC; Shao PL; Lu PL; Chen YH; Cheng SH; Ko WC; Lin CY; Wu TS; Yen MY; Wang LS; Liu CP; Lee WS; Shi ZY; Chen YS; Wang FD; Tseng SH; Lin CN; Chen YH; Sheng WH; Lee CM; Liao MH; Hsueh PR
    Int J Antimicrob Agents; 2019 Sep; 54(3):318-328. PubMed ID: 31202925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Investigation of Plasmid Mediated mcr Colistin Resistance Gene in Clinical Enterobacterales Isolates].
    Özkaya E; Buruk CK; Tosun İ; Toraman B; Kaklıkkaya N; Aydın F
    Mikrobiyol Bul; 2020 Apr; 54(2):191-202. PubMed ID: 32723275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of Colistin-Resistant, Gram-Negative Bacteria to Antimicrobial Peptides and Ceragenins.
    Hashemi MM; Rovig J; Weber S; Hilton B; Forouzan MM; Savage PB
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of Novel Amino Acid Alterations in PmrA or PmrB to Colistin Resistance in
    Sato T; Shiraishi T; Hiyama Y; Honda H; Shinagawa M; Usui M; Kuronuma K; Masumori N; Takahashi S; Tamura Y; Yokota SI
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of the type I signal peptidase inhibitor MD3 against multidrug-resistant Gram-negative bacteria alone and in combination with colistin.
    Personne Y; Curtis MA; Wareham DW; Waite RD
    J Antimicrob Chemother; 2014 Dec; 69(12):3236-43. PubMed ID: 25134721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The distribution of carbapenem- and colistin-resistance in Gram-negative bacteria from the Tamil Nadu region in India.
    Manohar P; Shanthini T; Ayyanar R; Bozdogan B; Wilson A; Tamhankar AJ; Nachimuthu R; Lopes BS
    J Med Microbiol; 2017 Jul; 66(7):874-883. PubMed ID: 28671537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
    Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles.
    van der Weide H; Vermeulen-de Jongh DMC; van der Meijden A; Boers SA; Kreft D; Ten Kate MT; Falciani C; Pini A; Strandh M; Bakker-Woudenberg IAJM; Hays JP; Goessens WHF
    Int J Antimicrob Agents; 2019 Aug; 54(2):159-166. PubMed ID: 31173867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
    Doymaz MZ; Karaaslan E
    Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061
    [No Abstract]   [Full Text] [Related]  

  • 16. Rough-type and loss of the LPS due to lpx genes deletions are associated with colistin resistance in multidrug-resistant clinical Escherichia coli isolates not harbouring mcr genes.
    Moosavian M; Emam N; Pletzer D; Savari M
    PLoS One; 2020; 15(5):e0233518. PubMed ID: 32433662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens.
    Lin L; Nonejuie P; Munguia J; Hollands A; Olson J; Dam Q; Kumaraswamy M; Rivera H; Corriden R; Rohde M; Hensler ME; Burkart MD; Pogliano J; Sakoulas G; Nizet V
    EBioMedicine; 2015 Jul; 2(7):690-8. PubMed ID: 26288841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efflux pump inhibitor CCCP to rescue colistin susceptibility in mcr-1 plasmid-mediated colistin-resistant strains and Gram-negative bacteria.
    Baron SA; Rolain JM
    J Antimicrob Chemother; 2018 Jul; 73(7):1862-1871. PubMed ID: 29718423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of the colistin resistance gene mcr-1 in colistin-resistant Escherichia coli and Klebsiella pneumoniae isolated from humans in Thailand.
    Eiamphungporn W; Yainoy S; Jumderm C; Tan-Arsuwongkul R; Tiengrim S; Thamlikitkul V
    J Glob Antimicrob Resist; 2018 Dec; 15():32-35. PubMed ID: 29935331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tryptamine derivatives disarm colistin resistance in polymyxin-resistant gram-negative bacteria.
    Barker WT; Chandler CE; Melander RJ; Ernst RK; Melander C
    Bioorg Med Chem; 2019 May; 27(9):1776-1788. PubMed ID: 30898435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.